Virbac rises after Q4 revenue growth

Virbac SA

17/01/2025 08:59

** Shares in Virbac  VIRB.PA  rise around 3% after the
company's revenue rose 10.5% in Q4 to 335.4 million euros
    ** Midcap Partners notes a 7.5% organic growth in entire
2024, driven by strong volume effects and double-digit growth in
most regions
    ** It flags, however, 2025 topline guidance challenges due
to high base effect and uncertainties in Chile and Australia,
which account for 10% of revenue
    ** Out of eight analysts that cover Virbac, four rate the
stock "strong buy" or "buy"​ and four rate it "hold" 

 (Reporting by Johan Bodinier)
 ((Johangeorgesroger.bodinier@thomsonreuters.com))